Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Beginning Cash Balance: 2018-2024

Historic Beginning Cash Balance for Eton Pharmaceuticals (ETON) over the last 7 years, with Dec 2024 value amounting to $21.4 million.

  • Eton Pharmaceuticals' Beginning Cash Balance rose 43.43% to $25.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.3 million, marking a year-over-year decrease of 8.20%. This contributed to the annual value of $21.4 million for FY2024, which is 31.17% up from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Beginning Cash Balance of $21.4 million as of FY2024, which was up 31.17% from $16.3 million recorded in FY2023.
  • Over the past 5 years, Eton Pharmaceuticals' Beginning Cash Balance peaked at $21.4 million during FY2024, and registered a low of $12.1 million during FY2020.
  • Over the past 3 years, Eton Pharmaceuticals' median Beginning Cash Balance value was $16.3 million (recorded in 2023), while the average stood at $17.4 million.
  • Its Beginning Cash Balance has fluctuated over the past 5 years, first crashed by 54.87% in 2020, then soared by 76.49% in 2021.
  • Yearly analysis of 5 years shows Eton Pharmaceuticals' Beginning Cash Balance stood at $12.1 million in 2020, then soared by 76.49% to $21.3 million in 2021, then slumped by 32.35% to $14.4 million in 2022, then rose by 13.18% to $16.3 million in 2023, then skyrocketed by 31.17% to $21.4 million in 2024.